Abstract
Abstract
Purpose
Nuclear medicine imaging modalities like computed tomography (CT), single photon emission CT (SPECT) and positron emission tomography (PET) are employed in the field of theranostics to estimate and plan the dose delivered to tumors and the surrounding tissues and to monitor the effect of the therapy. However, therapeutic radionuclides often provide poor images, which translate to inaccurate treatment planning and inadequate monitoring images. Multimodality information can be exploited in the reconstruction to enhance image quality. Triple modality PET/SPECT/CT scanners are particularly useful in this context due to the easier registration process between images. In this study, we propose to include PET, SPECT and CT information in the reconstruction of PET data. The method is applied to Yttrium-90 ($$^{90}$$
90
Y) data.
Methods
Data from a NEMA phantom filled with $$^{90}$$
90
Y were used for validation. PET, SPECT and CT data from 10 patients treated with Selective Internal Radiation Therapy (SIRT) were used. Different combinations of prior images using the Hybrid kernelized expectation maximization were investigated in terms of VOI activity and noise suppression.
Results
Our results show that triple modality PET reconstruction provides significantly higher uptake when compared to the method used as standard in the hospital and OSEM. In particular, using CT-guided SPECT images, as guiding information in the PET reconstruction significantly increases uptake quantification on tumoral lesions.
Conclusion
This work proposes the first triple modality reconstruction method and demonstrates up to 69% lesion uptake increase over standard methods with SIRT $$^{90}$$
90
Y patient data. Promising results are expected for other radionuclide combination used in theranostic applications using PET and SPECT.
Funder
EPSRC
National Measurement System of the UK’s Department for Business, Energy and Industrial Strategy
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,Instrumentation,Biomedical Engineering,Radiation
Reference39 articles.
1. Verel I, Visser GW, Van Dongen GA. The promise of immuno-pet in radioimmunotherapy. J Nucl Med. 2005;46(1 suppl):164–71.
2. Gomes Marin JF, Nunes RF, Coutinho AM, Zaniboni EC, Costa LB, Barbosa FG, Queiroz MA, Cerri GG, Buchpiguel CA. Theranostics in nuclear medicine: emerging and re-emerging integrated imaging and therapies in the era of precision oncology. Radiographics. 2020;40(6):1715–40.
3. Clinical Commissioning Policy: Selective internal radiation therapy (SIRT) for chemotherapy refractory intolerant metastatic colorectal cancer (adults)
4. Selective internal radiation therapies for treating hepatocellular carcinoma. https://www.nice.org.uk/guidance/ta688. Published: 2021-03-31
5. Chiesa C, Sjogreen-Gleisner K, Walrand S, Strigari L, Flux G, Gear J, Stokke C, Gabina PM, Bernhardt P, Konijnenberg M. Eanm dosimetry committee series on standard operational procedures: a unified methodology for 99mtc-maa pre-and 90y peri-therapy dosimetry in liver radioembolization with 90y microspheres. EJNMMI Phys. 2021;8(1):1–44.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献